Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14767019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.

  2002cited by this paper
• Advanced glycation end products and the progressive course of renal disease.

  2001cited by this paper
• Plasma levels of advanced glycation end products in children with renal disease

  2001cited by this paper
• N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function.

  2001cited by this paper
• Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").

  2001cited by this paper
• Clinical importance of thrombomodulin serum levels.

  2000cited by this paper
• Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.

  1999cited by this paper
• The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation.

  1999cited by this paper
• Methylglyoxal Modification of Protein

  1999cited by this paper
• Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation

  1999cited by this paper
• N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression*

  1999cited by this paper
• Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.

  1999cited by this paper
• Chemical modification of proteins by methylglyoxal.

  1998cited by this paper
• Serum Levels of Soluble Adhesion Molecules in Chronic Renal Failure and Dialysis Patients

  1998cited by this paper
• Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin.

  1997cited by this paper
• Synthesis and secretion of tumour necrosis factor-alpha by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts.

  1997cited by this paper
• The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*)

  1996cited by this paper
• Serum creatinine and urea: make the most of these simple test.

  1996cited by this paper
• Advanced glycosylation end products in patients with diabetic nephropathy.

  1991cited by this paper

• Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus

  2025cites this paper
• Adaptive Graph Prompting Meets Contrastive Learning: A Multi-View Framework for Metabolite-Disease Association Prediction.

  2025cites this paper
• Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons

  2025cites this paper
• Inhibitory effect of homemade hawthorn vinegar-based marinade on Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine formation in beef tenderloins.

  2024cites this paper
• Quantifying carboxymethyl lysine and carboxyethyl lysine in human plasma: clinical insights into aging research using liquid chromatography-tandem mass spectrometry

  2024cites this paper
• Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes

  2024cites this paper
• High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery

  2022cites this paper
• High serum levels of CML are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery

  2022cites this paper
• The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases

  2022cites this paper
• Genotoxicity of advanced glycation end products in vitro is influenced by their preparation temperature, purification, and cell exposure time.

  2021cites this paper
• In Vitro Evaluation of the Toxicological Profile and Oxidative Stress of Relevant Diet-Related Advanced Glycation End Products and Related 1,2-Dicarbonyls

  2021cites this paper
• Advanced glycation end products in food and their effects on intestinal tract

  2020cites this paper
• Possible association between haemostasis dysfunction and early onset of microvascular complications in patients with type 1 diabetes.

  2020cites this paper
• Trapa bispinosa Roxb. and lutein ameliorate cataract in type 1 diabetic rats

  2019cites this paper
• Serum AGEs and sRAGE levels are not related to vascular complications in patients with prediabetes.

  2019cites this paper
• Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus

  2019cites this paper
• High-throughput quantification of carboxymethyl lysine in serum and plasma using high-resolution accurate mass Orbitrap mass spectrometry

  2019cites this paper
• Antidiabetic effects of extracts of red and yellow fruits of cornelian cherries (Cornus mas L.) on rats with streptozotocin-induced diabetes mellitus.

  2019cites this paper
• Antidiabetic e ff ects of extracts of red and yellow fruits of cornelian cherries ( Cornus mas L . ) on rats with streptozotocin-induced diabetes mellitus

  2019cites this paper
• Advanced glycation end products in the pathogenesis of chronic kidney disease.

  2018cites this paper
• Gold Nanoparticle-Based Detection of Low Molecular Weight AGEs from In Vitro Glycated Haemoglobin A0 Samples

  2018cites this paper
• Impact of free Nε-carboxymethyllysine, its precursor glyoxal and AGE-modified BSA on serotonin release from human parietal cells in culture

  2018cites this paper
• Valorization

  2018cites this paper
• The advanced glycation end product Nϵ‐carboxymethyllysine and its precursor glyoxal increase serotonin release from Caco‐2 cells

  2018cites this paper
• University of Groningen The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress , Inflammation , Disease Severity , and Mortality during ICU Admission in Critically Ill Patients

  2017cites this paper
• Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

  2017cites this paper
• Heart rate variability and plasma biomarkers in patients with type 1 diabetes mellitus: Effect of a bout of aerobic exercise.

  2016cites this paper
• The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admission in Critically Ill Patients: Results from a Prospective Pilot Study

  2016cites this paper
• Houttuynia cordata aqueous extract attenuated glycative and oxidative stress in heart and kidney of diabetic mice

  2016cites this paper
• Pathways of the Maillard reaction under physiological conditions

  2016cites this paper
• Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect

  2016cites this paper
• Nϵ‐Carboxymethyllysine Increases the Expression of miR‐103/143 and Enhances Lipid Accumulation in 3T3‐L1 Cells

  2016influential citation
• Oxidation as an important factor of protein damage: Implications for Maillard reaction

  2015cites this paper
• Chitosan Prevents Gentamicin-Induced Nephrotoxicity via a Carbonyl Stress-Dependent Pathway

  2015cites this paper
• Advanced Glycation-Modified Human Serum Albumin Evokes Alterations in Membrane and Eryptosis in Erythrocytes

  2015cites this paper
• Is It Beneficial to Convert to a Neutral-pH Bicarbonate/Lactate-Buffered PD Solution in Long-Term CAPD Patients? A Single-Center Prospective Study

  2015cites this paper
• Effect of Nɛ-carboxymethyllysine on oxidative stress and the glutathione system in beta cells

  2014cites this paper
• Gender-related effects of advanced glycation end products on cardiac and renal function

  2014cites this paper
• Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients

  2013cites this paper
• N(ε)-Carboxymethyllysine (CML), a Maillard reaction product, stimulates serotonin release and activates the receptor for advanced glycation end products (RAGE) in SH-SY5Y cells.

  2013cites this paper
• Uptake of advanced glycation end products by proximal tubule epithelial cells via macropinocytosis.

  2013cites this paper
• Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseases.

  2013cites this paper
• Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.

  2013cites this paper
• Amelioration effects of berberine on diabetic microendothelial injury model by the combination of high glucose and advanced glycation end products in vitro.

  2011cites this paper
• Intracellular glycation and endothelial dysfunction : role of methylglyoxal

  2011cites this paper
• Relationship between advanced glycation end products and increased lipid peroxidation in semen of diabetic men.

  2011cites this paper
• Moderate glycation of serum albumin affects folding, stability, and ligand binding.

  2011cites this paper
• Chips from chips: application to the study of antibody responses to methylated proteins.

  2010cites this paper
• Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma.

  2010cites this paper
• Plasma levels of advanced glycation end products are associated with haemolysis‐related organ complications in sickle cell patients

  2010cites this paper
• Advanced glycation end‐products and the kidney

  2010cites this paper
• Diabetes mellitus: a prothrombotic state Implications for outcomes after coronary revascularization

  2009cites this paper
• Advanced glycation endproducts in sepsis and mechanical ventilation: extra or leading man?

  2009cites this paper
• Plasma Protein Pentosidine and Carboxymethyllysine, Biomarkers for Age-related Macular Degeneration*

  2009cites this paper
• Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes.

  2009cites this paper
• Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study

  2009cites this paper
• Advanced glycation end‐products activate extracellular signal‐regulated kinase via the oxidative stress‐EGF receptor pathway in renal fibroblasts

  2009influential citation
• Serum Levels of the Advanced Glycation End Products Nε-Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension

  2008cites this paper
• Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

  2008cites this paper
• Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?

  2008cites this paper
• Protective effects of morroniside isolated from Corni Fructus against renal damage in streptozotocin-induced diabetic rats.

  2008cites this paper
• Identification of antidiabetic effect of iridoid glycosides and low molecular weight polyphenol fractions of Corni Fructus, a constituent of Hachimi-jio-gan, in streptozotocin-induced diabetic rats.

  2007cites this paper
• Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes

  2007cites this paper
• Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications

  2007cites this paper
• Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor‐β: implications for diabetic atherosclerosis

  2007cites this paper
• Advanced glycation endproducts: what is their relevance to diabetic complications?

  2007cites this paper
• Diabetes mellitus as a prothrombotic condition

  2007cites this paper
• Posttranslationally modified proteins as mediators of sustained intestinal inflammation.

  2006cites this paper
• Concanavalin A, but not glycated albumin, increases subendothelial deposition of von Willebrand factor in vitro.

  2006cites this paper
• Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.

  2006cites this paper
• Cardiovascular Disease in Diabetic Nephropathy Patients: Cell Adhesion Molecules as Potential Markers?

  2005cites this paper
• Renal glomerular permselectivity and vascular endothelium.

  2005cites this paper
• Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.

  2005cites this paper
• Glycation Products as Markers and Predictors of the Progression of Diabetic Complications

  2005cites this paper
• Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes—the EURODIAB Prospective Complications Study

  2005cites this paper
• Superior Patient Survival for Continuous Ambulatory Peritoneal Dialysis Patients Treated with a Peritoneal Dialysis Fluid with Neutral pH and Low Glucose Degradation Product Concentration (Balance)

  2005cites this paper
• Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease.

  2003cites this paper